Nasdaq-listed Quantum BioPharma R&D Focused Business, Developing Solutions and Treatments

Quantum BioPharma is developing a portfolio of products including Quantum's Lucid-MS drug development and their drink, unbuzzd. In this episode, Adam Torres and Jason Sawyer, Head of Finance & M&A at Quantum BioPharma, explore Quantum BioPharma.

Follow Adam on Instagram at https://www.instagram.com/askadamtorres/ for up to date information on book releases and tour schedule.

Apply to be a guest on our podcast:
https://missionmatters.lpages.co/podcastguest/

Visit our website:
https://missionmatters.com/

More FREE content from Mission Matters here: https://linktr.ee/missionmattersmedia
Learn more about your ad choices. Visit podcastchoices.com/adchoices